Nemes Rush Group’s GSK GSK Stock Holding History

Nemes Rush Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.06K	Hold	188	–	–	﹤0.01%	573
2026 Q2	$9.9K	Hold	188	–	–	﹤0.01%	579
2026 Q1	$10.4K	Hold	188	–	–	﹤0.01%	543
2025 Q4	$9.22K	Buy	188 +98	+109%	+$4.57K	﹤0.01%	558
2025 Q3	$3.88K	Hold	90	–	–	﹤0.01%	566
2025 Q2	$3.46K	Hold	90	–	–	﹤0.01%	570
2025 Q1	$3.49K	Hold	90	–	–	﹤0.01%	565
2024 Q4	$3.04K	Buy	+90	New	+$3.24K	﹤0.01%	585
2024 Q2	–	Sell	-1,201	Closed	-$51.5K	–	635
2024 Q1	$51.5K	Hold	1,201	–	–	0.01%	269
2023 Q4	$44.5K	Hold	1,201	–	–	0.01%	267
2023 Q3	$43.5K	Sell	1,201 -150	-11%	-$5.32K	0.01%	267
2023 Q2	$48.2K	Buy	+1,351	New	+$48.5K	0.01%	267

Other funds holding GSK

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nemes Rush Group's GSK Position: Q3 2026 in Review

Nemes Rush Group held its GSK (GSK) position steady in Q3 2026 at 188 shares worth $9.06K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Nemes Rush Group first reported a position in GSK in Q2 2023 and has held it in 12 quarters since. The position peaked at $51.5K in Q1 2024. 558 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Nemes Rush Group held 188 shares of GSK worth $9.06K as of Q3 2026.
Nemes Rush Group left its GSK share count unchanged in Q3 2026.
GSK made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #573 holding.
Nemes Rush Group first reported a position in GSK in Q2 2023 and has held it in 12 quarters since.
Nemes Rush Group's GSK position peaked at $51.5K in Q1 2024.
558 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.